26 April 2021Cybin (CYBN.NE) to target alcoholism in their CYB003 clinical studiesPiers Eaton CYBN.NE Cybin (CYBN.NE) announced that they will be using Alcohol Use Disorder (AUD) as the initial target indication for their proprietary psychedelic molecule, CYB003. “AUD is a chronic relapsing brain…